Viagra for Cramps? (from CRAMPED)

This episode of Cramped, hosted by Kate Helen Downey, dives into the overlooked and underfunded world of period pain research, spotlighting a groundbreaking yet abandoned study on sildenafil citrate (Viagra) as a potential treatment for severe menstrual cramps. The episode traces how a drug originally developed for heart disease in men was repurposed for erectile dysfunction, but its potential application for women’s pain—due to its ability to relax uterine blood vessels via vasodilation—was never pursued despite promising early results. A 2013 Penn State study found that a vaginal form of sildenafil reduced pain from an average of 93/100 to 9/100 within four hours, with no side effects, but was halted due to lack of funding and dismissive grant reviews that deemed dysmenorrhea 'not a priority.' The episode critiques systemic gender bias in medical research, citing the exclusion of women in early trials and the pharmaceutical industry’s reluctance to invest in women’s health when profits are already secured in male markets. It ends on a hopeful note by highlighting emerging treatments from companies like DARE Bioscience, Viramal, and PNB Vesper Life Sciences, offering real-world progress in the field. The narrative underscores a powerful message: persistent questioning of 'why aren't we studying this?' can drive change. Key takeaways include: 1) Period pain is a major public health issue affecting millions, yet remains underfunded and understudied; 2) A vaginal form of Viagra showed dramatic pain relief in a small study but was abandoned due to systemic neglect; 3) Gender bias in clinical research and funding decisions perpetuates inequity; 4) New treatments targeting inflammation, local delivery, and hormone modulation are emerging; 5) Advocacy and public pressure are essential to shift priorities in medical research.